Can anyone please share your policy and annual questionnaire regarding hazardous drugs with me? Your assistance is greatly appreciated.
Cathy Senior RN BSN CDE
Employee Health Director
Penn Highlands DuBois
100 Hospital Avenue
P.O. Box 447
DuBois Pa 15801
Phone 814-375-3392
Fax 814-372-2610
cesenior@phhealthcare.org
www.phhealthcare.org
From: MCOH-EH [mailto:mcoh-eh-bounces@mylist.net]
On Behalf Of Seeburger, Sara
Sent: Friday, September 01, 2017 10:13 AM
To: MCOH/EH <mcoh-eh@mylist.net>
Subject: Re: [MCOH-EH] [EXTERNAL] hazardous drug administration
CBC, UA, CMP, reproductive health questionnaire
Sara Seeburger RN, BSN
Assistant Administrator
Centura Occupational Health
9100 E. Mineral Circle
Centennial, CO 80112
303-765-6498 Phone
720-874-5955 Fax
From: MCOH-EH [mailto:mcoh-eh-bounces@mylist.net]
On Behalf Of Morelli, Karen J
Sent: Friday, September 01, 2017 8:09 AM
To: MCOH/EH <mcoh-eh@mylist.net>
Subject: Re: [MCOH-EH] [EXTERNAL] hazardous drug administration
What components are you monitoring?
Thank you,
Karen Morelli RN, BSN, Clinical Manager
WorkHealth LLC
Eastern Maine Healthcare Systems
From: MCOH-EH [mailto:mcoh-eh-bounces+kmorelli=emhs.org@mylist.net]
On Behalf Of Seeburger, Sara
Sent: Friday, September 01, 2017 10:06 AM
To: MCOH/EH
Subject: Re: [MCOH-EH] [EXTERNAL] hazardous drug administration
*********************************************************************************************************************************************
The e-mail below is from an external source. Please do not open attachments or click links from an unknown or suspicious source.
*********************************************************************************************************************************************
We have a program in our hospitals. The program is voluntary at this time, so there is no compliance tracking. We extend invitations to all Pharmacy staff
and to nurses who routinely administer hazardous drugs each year and upon hire. We are considering their first visit a baseline (regardless of if they have worked for us for many years, we had to start somewhere). For those with abnormal results, our Occ
Health Physicians handle those case by case, so I suppose they may do follow up testing or in some cases refer them to their own providers. As for the USP800, we are looking into that and will update our policies but have not done so yet.
Hope that helps!
Sara Seeburger RN, BSN
Assistant Administrator
Centura Occupational Health
9100 E. Mineral Circle
Centennial, CO 80112
303-765-6498 Phone
720-874-5955 Fax
From: MCOH-EH [mailto:mcoh-eh-bounces@mylist.net]
On Behalf Of Morelli, Karen J
Sent: Friday, September 01, 2017 6:39 AM
To: MCOH/EH <mcoh-eh@mylist.net>
Subject: Re: [MCOH-EH] [EXTERNAL] hazardous drug administration
I, too, would love to see if anyone has a hazardous drug surveillance program in place as our system is looking at this as well.
Karen Morelli RN, BSN
Clinical Manager
WorkHealth LLC
Eastern Maine Healthcare Systems
From: MCOH-EH [mailto:mcoh-eh-bounces@mylist.net]
On Behalf Of Angeli Mancuso
Sent: Thursday, August 31, 2017 4:59 PM
To: MCOH/EH
Subject: Re: [MCOH-EH] [EXTERNAL] hazardous drug administration
*********************************************************************************************************************************************
The e-mail below is from an external source. Please do not open attachments or click links from an unknown or suspicious source.
*********************************************************************************************************************************************
Hi all,
I sincerely appreciate the input and perspectives from this group. I have some follow up questions that I’m curious how others are handling:
I’ve really appreciated the shared policies and forms from everyone! Thanks for being such a great community!
Angeli Mancuso, RN, COHN-S/CM
Manager, Employee Health & Safety | Cottage Health
P.O Box 689 | 400 W. Pueblo St | Santa Barbara, CA 93102-0689
Office: (805) 569-7866 | Fax: (805) 569-8271
From: MCOH-EH [mailto:mcoh-eh-bounces@mylist.net]
On Behalf Of Allen-Hardy, Blythe
Sent: Tuesday, August 01, 2017 3:39 PM
To: MCOH/EH
Subject: Re: [MCOH-EH] [EXTERNAL] hazardous drug administration
I’m fairly new to the organization so still learning how it is determined who’s in the program. I’m assuming that a list is giving to occur health by the director
of oncology nursing. I can respond back once I get further clarification.
Blythe Allen-Hardy, MD, FACOEM
Medical Director, Employee Health
Texas Medical Center
6411 Fannin, JB500
Houston, Texas, 77030
W: 713-704-2792
C: 720-840-9593
F: 713-704-6350
From: MCOH-EH [mailto:mcoh-eh-bounces@mylist.net]
On Behalf Of Thrasher, Terri
Sent: Tuesday, August 01, 2017 1:34 PM
To: MCOH/EH
Subject: Re: [MCOH-EH] [EXTERNAL] hazardous drug administration
How do you determine who to place in surveillance and how many employees are you running through the surveillance labs?
Terri
Kindest regards,
Terri
Terri L. Thrasher RN MSN
Sr. Director HR
Employee Health, Occupational Safety, Environmental Health, Employee Relations, Leave Management HR Compliance/Policy, Workers Compensation, 803-SAFE, Injury
Management, Non CCHMC Badging, Early Education and Childcare Center
3333 Burnet Ave
Cincinnati Ohio 45229 MLC 9006
513-636-6240
From: MCOH-EH [mailto:mcoh-eh-bounces@mylist.net]
On Behalf Of Allen-Hardy, Blythe
Sent: Tuesday, August 01, 2017 2:22 PM
To: 'MCOH/EH' <mcoh-eh@mylist.net>
Subject: Re: [MCOH-EH] [EXTERNAL] hazardous drug administration
Cathy,
At Memorial Hermann we have a surveillance program that I am in the process of updating due to the USP 800 requirements. We have a policy in place in our hospitals
on how the drugs are handled etc and it is fairly comprehensive. The medical surveillance I believe as involved checking a CBC, UA and completing an annual questionnaire. I am developing a medical surveillance guideline that will addl laboratory tests such
as LFT’s, BUN/Cr to the CBC w/diff and UA. Will also add a focused exam component for post exposures.
That may be overkill but I want to make sure we have a comprehensive program. Feel free to contact me for further questions.
Blythe Allen-Hardy, MD, FACOEM
Medical Director, Employee Health
Texas Medical Center
6411 Fannin, JB500
Houston, Texas, 77030
W: 713-704-2792
C: 720-840-9593
F: 713-704-6350
From: MCOH-EH [mailto:mcoh-eh-bounces+blythe.allen-hardy=memorialhermann.org@mylist.net]
On Behalf Of Senior, Cathy (Employee Health)
Sent: Tuesday, August 01, 2017 11:42 AM
To: 'MCOH/EH'
Subject: [EXTERNAL] [MCOH-EH] hazardous drug administration
Does anyone have a
medical surveillance plan for employees who handle hazardous drugs. We are seeing more administration of these hazardous drugs between starting the intravesical therapy and the
biologics that are administered. We follow the ONS guidelines for safe handling of hazardous drugs as outlined in our policy. We already have the appropriate work practice in place including proper use of PPE and education for the staff that handle these drugs.
There has been a concern voiced by one of our educators that institutions such as NIOSH have recommendations for medical surveillance to make it a comprehensive prevention program that we do not have in place. Some of the drugs we administer is Carboplatin,
VP-16, Taxol, Cisplatin, Cytoxan, Erbitux, 5-FU, Abraxane, Gemzar, Herceptin, Parieto and Rituxan to name a few. We also give biologics to out-patients in our short stay unit. Any help would be much appreciated. Thanks
Cathy Senior RN BSN CDE
Employee Health Director
Penn Highlands DuBois
100 Hospital Avenue
P.O. Box 447
DuBois Pa 15801
Phone 814-375-3392
Fax 814-372-2610
This email and any attached files are sensitive in nature and intended solely for the intended recipient(s). If you are not the named recipient you should not read, distribute, copy or alter this email. Any views or opinions expressed in this email are those of the author and do not represent those of Penn Highlands Healthcare or its affiliates.. Warning: Although precautions have been taken to make sure no viruses are present in this email, the company cannot accept responsibility for any loss or damage that arise from the use of this email or attachments.
CH Disclaimer: This electronic mail message is intended exclusively for the individual or entity to which it is addressed. This message, together with any attachment, may contain confidential
and privileged information. Any views, opinions or conclusions expressed in this message are those of the individual sender and do not necessarily reflect the views of Cottage Health, its subsidiaries or affiliates. This document may also contain information
covered under the Health Insurance Portability and Accountability Act (HIPAA, PL 104-191) and implementing regulations and must be protected in accordance with those provisions. Re-disclosure without patient consent or as otherwise permitted by law is prohibited.
Any unauthorized review, retransmission, use, printing, copying, retention, disclosure, distribution or the taking of any action in reliance upon this information by persons or entities other than the intended recipient is strictly prohibited and may be unlawful.
If you have received this message in error, please immediately advise the sender by reply email message to the sender and delete all copies of this message from your system without copying.
*****************************************************************************
This communication is for the use of the intended recipient only. It may
contain information that is privileged and confidential. If you are not the
intended recipient of this communication, any disclosure, copying, further
distribution or use thereof is prohibited. If you have received this
communication in error, please advise me by return e-mail or by telephone and
delete/destroy it.
*****************************************************************************
*****************************************************************************
This communication is for the use of the intended recipient only. It may
contain information that is privileged and confidential. If you are not the
intended recipient of this communication, any disclosure, copying, further
distribution or use thereof is prohibited. If you have received this
communication in error, please advise me by return e-mail or by telephone and
delete/destroy it.
*****************************************************************************
This email and any attached files are sensitive in nature and intended solely for the intended recipient(s). If you are not the named recipient you should not read, distribute, copy or alter this email. Any views or opinions expressed in this email are those of the author and do not represent those of Penn Highlands Healthcare or its affiliates.. Warning: Although precautions have been taken to make sure no viruses are present in this email, the company cannot accept responsibility for any loss or damage that arise from the use of this email or attachments.